Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer.
Publication
, Conference
LaCroix, BL; Patierno, BM; Sullenger, BA; George, DJ; Patierno, SR; Freedman, JA
Published in: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
July 1, 2018
Duke Scholars
Published In
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
EISSN
1538-7755
ISSN
1055-9965
Publication Date
July 1, 2018
Volume
27
Issue
7
Start / End Page
46 / 46
Location
Atlanta, GA
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
10th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
Related Subject Headings
- Epidemiology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
LaCroix, B. L., Patierno, B. M., Sullenger, B. A., George, D. J., Patierno, S. R., & Freedman, J. A. (2018). Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer. In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (Vol. 27, pp. 46–46). Atlanta, GA: AMER ASSOC CANCER RESEARCH.
LaCroix, Bonnie L., Brendon M. Patierno, Bruce A. Sullenger, Daniel J. George, Steven R. Patierno, and Jennifer A. Freedman. “Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer.” In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 27:46–46. AMER ASSOC CANCER RESEARCH, 2018.
LaCroix BL, Patierno BM, Sullenger BA, George DJ, Patierno SR, Freedman JA. Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer. In: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. AMER ASSOC CANCER RESEARCH; 2018. p. 46–46.
LaCroix, Bonnie L., et al. “Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer.” CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, vol. 27, no. 7, AMER ASSOC CANCER RESEARCH, 2018, pp. 46–46.
LaCroix BL, Patierno BM, Sullenger BA, George DJ, Patierno SR, Freedman JA. Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. AMER ASSOC CANCER RESEARCH; 2018. p. 46–46.
Published In
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
EISSN
1538-7755
ISSN
1055-9965
Publication Date
July 1, 2018
Volume
27
Issue
7
Start / End Page
46 / 46
Location
Atlanta, GA
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
10th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
Related Subject Headings
- Epidemiology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences